Rev Med Suisse. 2025 Jan 22;21(902):147-149. doi: 10.53738/REVMED.2025.21.902.147.
ABSTRACT
This article highlights recent advancements in otorhinolaryngology. It reviews innovations in managing sudden sensory-neural hearing loss through low-dose glucocorticoid treatments and explores pediatric audiology breakthroughs, particularly gene therapy for DFNB9 deafness. In speech pathology and oncology, a new minimally invasive robotic surgical approach enhances organ preservation for head and neck cancers. Rhinology advancements include biological therapies for chronic rhinosinusitis with polyps. Together, these developments expand therapeutic options, significantly improving patient quality of life in the ORL field.
PMID:39846100 | DOI:10.53738/REVMED.2025.21.902.147
